These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

112 related articles for article (PubMed ID: 37704496)

  • 1. Association between waist circumference trajectories and incident non-alcoholic fatty liver disease.
    Lee JH; Jeon S; Lee HS; Kwon YJ
    Obes Res Clin Pract; 2023; 17(5):398-404. PubMed ID: 37704496
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Gender Differences in the Risk for Incident Non-Alcoholic Fatty Liver Disease According to the Transition of Abdominal Obesity Status: A 16-Year Cohort Study.
    Lee JH; Jeon S; Lee HS; Kwon YJ
    Nutrients; 2023 Jun; 15(13):. PubMed ID: 37447207
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Cutoff Points of Waist Circumference for Predicting Incident Non-Alcoholic Fatty Liver Disease in Middle-Aged and Older Korean Adults.
    Lee JH; Jeon S; Lee HS; Kwon YJ
    Nutrients; 2022 Jul; 14(14):. PubMed ID: 35889950
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Skeletal muscle mass and abdominal obesity are independent predictors of hepatic steatosis and interact to predict ten-year cardiovascular disease incidence: Data from the ATTICA cohort study.
    Kouvari M; Polyzos SA; Chrysohoou C; Skoumas J; Pitsavos CS; Panagiotakos DB; Mantzoros CS
    Clin Nutr; 2022 Jun; 41(6):1281-1289. PubMed ID: 35504171
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Relationship between waist circumference trajectory and new-onset non alcoholic fatty liver disease in the non-obese population].
    Wang S; Zhang J; Jiang XZ; Tong B; Wang Q; Zhang WH; Yang YY; Xia JX; Wu SL
    Zhonghua Liu Xing Bing Xue Za Zhi; 2020 Jun; 41(6):824-828. PubMed ID: 32564543
    [No Abstract]   [Full Text] [Related]  

  • 6. [Predictive value of body mass index combined with waist circumference for new-onset nonalcoholic fatty liver disease in patients with type 2 diabetes mellitus].
    Wang S; Zhang J; Zhang W; Wang H; Hou J; Zhang R; Liu H; Wu S
    Nan Fang Yi Ke Da Xue Xue Bao; 2019 Nov; 39(11):1293-1297. PubMed ID: 31852647
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Associations Between Abdominal Obesity Indices and Nonalcoholic Fatty Liver Disease: Chinese Visceral Adiposity Index.
    Chen X; Shi F; Xiao J; Huang F; Cheng F; Wang L; Ju Y; Zhou Y; Jia H
    Front Endocrinol (Lausanne); 2022; 13():831960. PubMed ID: 35360076
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Waist Gain Is Associated with a Higher Incidence of Nonalcoholic Fatty Liver Disease in Korean Adults: A Cohort Study.
    Yun KE; Nam GE; Lim J; Park HS; Chang Y; Jung HS; Kim CW; Ko BJ; Chung EC; Shin H; Ryu S
    PLoS One; 2016; 11(7):e0158710. PubMed ID: 27420035
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Fatty liver index vs waist circumference for predicting non-alcoholic fatty liver disease.
    Motamed N; Sohrabi M; Ajdarkosh H; Hemmasi G; Maadi M; Sayeedian FS; Pirzad R; Abedi K; Aghapour S; Fallahnezhad M; Zamani F
    World J Gastroenterol; 2016 Mar; 22(10):3023-30. PubMed ID: 26973398
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Association between the lean nonalcoholic fatty liver disease and risk of incident type 2 diabetes in a healthy population of Northwest China: a retrospective cohort study with a 2-year follow-up period.
    Li N; Xang W; Wu S; Li D; Chang M; Xie C; Zhang MY; Tan H
    Front Endocrinol (Lausanne); 2023; 14():1173757. PubMed ID: 37435491
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The value of combining the simple anthropometric obesity parameters, Body Mass Index (BMI) and a Body Shape Index (ABSI), to assess the risk of non-alcoholic fatty liver disease.
    Kuang M; Sheng G; Hu C; Lu S; Peng N; Zou Y
    Lipids Health Dis; 2022 Oct; 21(1):104. PubMed ID: 36266655
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The visceral adiposity index is a predictor of incident nonalcoholic fatty liver disease: A population-based longitudinal study.
    Okamura T; Hashimoto Y; Hamaguchi M; Obora A; Kojima T; Fukui M
    Clin Res Hepatol Gastroenterol; 2020 Jun; 44(3):375-383. PubMed ID: 32434704
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Sex-specific metabolic risk factors and their trajectories towards the non-alcoholic fatty liver disease incidence.
    Tong C; Li Q; Kong L; Ni X; Halengbieke A; Zhang S; Wu Z; Tao L; Han Y; Zheng D; Guo X; Yang X
    J Endocrinol Invest; 2022 Dec; 45(12):2233-2245. PubMed ID: 35896944
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Central obesity and nonalcoholic fatty liver disease risk after adjusting for body mass index.
    Pang Q; Zhang JY; Song SD; Qu K; Xu XS; Liu SS; Liu C
    World J Gastroenterol; 2015 Feb; 21(5):1650-62. PubMed ID: 25663786
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A combined association of serum uric acid, alanine aminotransferase and waist circumference with non-alcoholic fatty liver disease: a community-based study.
    Wang M; Wang M; Zhang R; Zhang L; Ding Y; Tang Z; Fan H; Wang H; Zhang W; Chen Y; Wang J
    PeerJ; 2022; 10():e13022. PubMed ID: 35265397
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Association between metabolically healthy obesity and non-alcoholic fatty liver disease.
    Man S; Lv J; Yu C; Deng Y; Yin J; Wang B; Li L; Liu H
    Hepatol Int; 2022 Dec; 16(6):1412-1423. PubMed ID: 35987840
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Association of changes in body mass index and waist circumference with cardiovascular risk in non-alcoholic fatty liver disease: A nationwide study.
    Jang SY; Kim HJ; Chang JY
    Dig Liver Dis; 2023 Nov; 55(11):1509-1514. PubMed ID: 37419727
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Association of non-high-density lipoprotein cholesterol trajectories with the development of non-alcoholic fatty liver disease: an epidemiological and genome-wide association study.
    Lee JH; Kim J; Kim JO; Kwon YJ
    J Transl Med; 2023 Jul; 21(1):435. PubMed ID: 37403158
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Prevalence, clinical characteristics, risk factors, and indicators for lean Chinese adults with nonalcoholic fatty liver disease.
    Zeng J; Yang RX; Sun C; Pan Q; Zhang RN; Chen GY; Hu Y; Fan JG
    World J Gastroenterol; 2020 Apr; 26(15):1792-1804. PubMed ID: 32351294
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Risk for the development of non-alcoholic fatty liver disease: A prospective study.
    Wang J; Ma L; Chen S; Xu L; Miao M; Yu C; Li Y; Xu C
    J Gastroenterol Hepatol; 2018 Aug; 33(8):1518-1523. PubMed ID: 29381226
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.